Inventor
MILNER PETER G
US38 patents
⚠️ This page may combine multiple inventors who share the name “MILNER PETER G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARYX THERAPEUTICS
14 patentsUS6680387B2Jan 20, 2004
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
ARYX THERAPEUTICS21 citations92
US6372783B1Apr 16, 2002
Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
ARYX THERAPEUTICS21 citations92
US6362223B1Mar 26, 2002
Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
ARYX THERAPEUTICS20 citations92
US6316487B1Nov 13, 2001
Compounds for treatment of cardiac arrhythmia synthesis, and methods of use
ARYX THERAPEUTICS20 citations92
US6114344ASep 5, 2000
Long-acting local anesthetics
ARYX THERAPEUTICS19 citations92
US6552046B2Apr 22, 2003
Materials and methods for the treatment of gastroesophageal reflux disease
ARYX THERAPEUTICS41 citations91
US6683086B2Jan 27, 2004
Ultrashort acting hypnotic barbiturates
ARYX THERAPEUTICS9 citations74
US6683195B2Jan 27, 2004
Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
ARYX THERAPEUTICS8 citations74
US6387914B2May 14, 2002
Ultrashort acting hypnotic barbiturates
ARYX THERAPEUTICS10 citations74
US6608097B2Aug 19, 2003
Materials and methods for the treatment of hypertension and angina
ARYX THERAPEUTICS4 citations62
US6818782B2Nov 16, 2004
Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
ARYX THERAPEUTICS0 citations52
US6784199B2Aug 31, 2004
Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
ARYX THERAPEUTICS1 citations52
US6768008B2Jul 27, 2004
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
ARYX THERAPEUTICS1 citations52
US7265142B2Sep 4, 2007
Materials and methods for the treatment of hypertension and angina
ARYX THERAPEUTICS0 citations51
CONJUCHEM INC
8 patentsUS6887470B1May 3, 2005
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
CONJUCHEM INC210 citations99
US6849714B1Feb 1, 2005
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
CONJUCHEM INC254 citations99
US6706892B1Mar 16, 2004
Pulmonary delivery for bioconjugation
CONJUCHEM INC151 citations97
US6500918B2Dec 31, 2002
Conjugate comprising an antinociceptive agent covalently bonded to a blood component
CONJUCHEM INC40 citations96
US6437092B1Aug 20, 2002
Conjugates of opioids and endogenous carriers
CONJUCHEM INC33 citations96
US6610825B2Aug 26, 2003
Method for alleviating pain or providing an analgesic effect in a patient
CONJUCHEM INC27 citations92
US6602981B2Aug 5, 2003
Antinociceptive agent derivative
CONJUCHEM INC26 citations92
US7090851B1Aug 15, 2006
Long lasting fusion peptide inhibitors of viral infection
CONJUCHEM INC29 citations89
ARYX THERAPEUTICS INC
5 patentsUS7041673B2May 9, 2006
Ultrashort acting hypnotic barbiturates
ARYX THERAPEUTICS INC2 citations63
USRE42412EMay 31, 2011
Materials and methods for the treatment of gastroesophageal reflux disease
ARYX THERAPEUTICS INC2 citations60
USRE41289EApr 27, 2010
Ultrashort acting hypnotic barbiturates
ARYX THERAPEUTICS INC0 citations52
US7022722B2Apr 4, 2006
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
ARYX THERAPEUTICS INC1 citations52
US6958355B2Oct 25, 2005
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
ARYX THERAPEUTICS INC0 citations42
CONJUCHEM BIOTECHNOLOGIES INC
4 patentsUS7256253B2Aug 14, 2007
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
CONJUCHEM BIOTECHNOLOGIES INC105 citations97
US7601691B2Oct 13, 2009
Anti-obesity agents
CONJUCHEM BIOTECHNOLOGIES INC27 citations91
US7582301B1Sep 1, 2009
Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides
CONJUCHEM BIOTECHNOLOGIES INC21 citations90
US7608271B2Oct 27, 2009
Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group
CONJUCHEM BIOTECHNOLOGIES INC5 citations68
UNIV FLORIDA
4 patentsUS5668139ASep 16, 1997
A1 adenosine receptor agonists and antagonists
UNIV FLORIDA49 citations95
US5736528AApr 7, 1998
N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
UNIV FLORIDA17 citations92
US5631260AMay 20, 1997
Xanthine epoxides as A1 adenosine receptor agonists and antagonists
UNIV FLORIDA29 citations92
US5998387ADec 7, 1999
Method for using A1 adenosine receptor agonists
UNIV FLORIDA16 citations81